MFA
VKTX icon

Mayflower Financial Advisors’s Viking Therapeutics VKTX Stock Holding History

Mayflower Financial Advisors’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,485
Closed -$225K – 371
2023
Q1 		$225K Hold
13,485
– – 0.03% 310
2022
Q4 		$127K Hold
13,485
– – 0.02% 331
2022
Q3 		$37K Hold
13,485
– – 0.01% 320
2022
Q2 		$39K Hold
13,485
– – 0.01% 317
2022
Q1 		$40K Hold
13,485
– – 0.01% 347
2021
Q4 		$62K Hold
13,485
– – 0.01% 334
2021
Q3 		$79K Sell
13,485
-500
-4% -$3.09K 0.01% 325
2021
Q2 		$84K Sell
13,985
-393
-3% -$2.33K 0.01% 310
2021
Q1 		$91K Sell
14,378
-1,400
-9% -$9.85K 0.01% 288
2020
Q4 		$89K Buy
+15,778
New +$95.6K 0.02% 272

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return